Cargando…
Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events
BACKGROUND: Familial hypercholesterolemia (FH) may arise from deleterious monogenic variants in FH‐causing genes as well as from a polygenic cause. We evaluated the relationships between monogenic FH and polygenic hypercholesterolemia in influencing the long‐term response to therapy and the risk of...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200757/ https://www.ncbi.nlm.nih.gov/pubmed/33890476 http://dx.doi.org/10.1161/JAHA.120.018932 |
_version_ | 1783707675592228864 |
---|---|
author | D’Erasmo, Laura Minicocci, Ilenia Di Costanzo, Alessia Pigna, Giovanni Commodari, Daniela Ceci, Fabrizio Montali, Anna Brancato, Francesca Stanca, Ilaria Nicolucci, Antonio Ascione, Andrea Galea, Nicola Carbone, Iacopo Francone, Marco Maranghi, Marianna Arca, Marcello |
author_facet | D’Erasmo, Laura Minicocci, Ilenia Di Costanzo, Alessia Pigna, Giovanni Commodari, Daniela Ceci, Fabrizio Montali, Anna Brancato, Francesca Stanca, Ilaria Nicolucci, Antonio Ascione, Andrea Galea, Nicola Carbone, Iacopo Francone, Marco Maranghi, Marianna Arca, Marcello |
author_sort | D’Erasmo, Laura |
collection | PubMed |
description | BACKGROUND: Familial hypercholesterolemia (FH) may arise from deleterious monogenic variants in FH‐causing genes as well as from a polygenic cause. We evaluated the relationships between monogenic FH and polygenic hypercholesterolemia in influencing the long‐term response to therapy and the risk of atherosclerosis. METHODS AND RESULTS: A cohort of 370 patients with clinically diagnosed FH were screened for monogenic mutations and a low‐density lipoprotein‐rising genetic risk score >0.69 to identify polygenic cause. Medical records were reviewed to estimate the response to lipid‐lowering therapies and the occurrence of major atherosclerotic cardiovascular events during a median follow‐up of 31.0 months. A subgroup of patients (n=119) also underwent coronary computed tomographic angiography for the evaluation of coronary artery calcium score and severity of coronary stenosis as compared with 135 controls. Two hundred nine (56.5%) patients with hypercholesterolemia were classified as monogenic (FH/M+), 89 (24.1%) as polygenic, and 72 (19.5%) genetically undefined (FH/M−). The response to lipid‐lowering therapy was poorest in monogenic, whereas it was comparable in patients with polygenic hypercholesterolemia and genetically undetermined. Mean coronary artery calcium score and the prevalence of coronary artery calcium >100 units were significantly higher in FH/M+ as compared with both FH/M− and controls. Finally, after adjustments for confounders, we observed a 5‐fold higher risk of incident major atherosclerotic cardiovascular events in FH/M+ (hazard ratio, 4.8; 95% CI, 1.06–21.36; P (adj)=0.041). CONCLUSIONS: Monogenic cause of FH is associated with lower response to conventional cholesterol‐lowering therapies as well as with increased burden of coronary atherosclerosis and risk of atherosclerotic‐related events. Genetic testing for hypercholesterolemia is helpful in providing important prognostic information. |
format | Online Article Text |
id | pubmed-8200757 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82007572021-06-15 Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events D’Erasmo, Laura Minicocci, Ilenia Di Costanzo, Alessia Pigna, Giovanni Commodari, Daniela Ceci, Fabrizio Montali, Anna Brancato, Francesca Stanca, Ilaria Nicolucci, Antonio Ascione, Andrea Galea, Nicola Carbone, Iacopo Francone, Marco Maranghi, Marianna Arca, Marcello J Am Heart Assoc Original Research BACKGROUND: Familial hypercholesterolemia (FH) may arise from deleterious monogenic variants in FH‐causing genes as well as from a polygenic cause. We evaluated the relationships between monogenic FH and polygenic hypercholesterolemia in influencing the long‐term response to therapy and the risk of atherosclerosis. METHODS AND RESULTS: A cohort of 370 patients with clinically diagnosed FH were screened for monogenic mutations and a low‐density lipoprotein‐rising genetic risk score >0.69 to identify polygenic cause. Medical records were reviewed to estimate the response to lipid‐lowering therapies and the occurrence of major atherosclerotic cardiovascular events during a median follow‐up of 31.0 months. A subgroup of patients (n=119) also underwent coronary computed tomographic angiography for the evaluation of coronary artery calcium score and severity of coronary stenosis as compared with 135 controls. Two hundred nine (56.5%) patients with hypercholesterolemia were classified as monogenic (FH/M+), 89 (24.1%) as polygenic, and 72 (19.5%) genetically undefined (FH/M−). The response to lipid‐lowering therapy was poorest in monogenic, whereas it was comparable in patients with polygenic hypercholesterolemia and genetically undetermined. Mean coronary artery calcium score and the prevalence of coronary artery calcium >100 units were significantly higher in FH/M+ as compared with both FH/M− and controls. Finally, after adjustments for confounders, we observed a 5‐fold higher risk of incident major atherosclerotic cardiovascular events in FH/M+ (hazard ratio, 4.8; 95% CI, 1.06–21.36; P (adj)=0.041). CONCLUSIONS: Monogenic cause of FH is associated with lower response to conventional cholesterol‐lowering therapies as well as with increased burden of coronary atherosclerosis and risk of atherosclerotic‐related events. Genetic testing for hypercholesterolemia is helpful in providing important prognostic information. John Wiley and Sons Inc. 2021-04-23 /pmc/articles/PMC8200757/ /pubmed/33890476 http://dx.doi.org/10.1161/JAHA.120.018932 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research D’Erasmo, Laura Minicocci, Ilenia Di Costanzo, Alessia Pigna, Giovanni Commodari, Daniela Ceci, Fabrizio Montali, Anna Brancato, Francesca Stanca, Ilaria Nicolucci, Antonio Ascione, Andrea Galea, Nicola Carbone, Iacopo Francone, Marco Maranghi, Marianna Arca, Marcello Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events |
title | Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events |
title_full | Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events |
title_fullStr | Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events |
title_full_unstemmed | Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events |
title_short | Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events |
title_sort | clinical implications of monogenic versus polygenic hypercholesterolemia: long‐term response to treatment, coronary atherosclerosis burden, and cardiovascular events |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200757/ https://www.ncbi.nlm.nih.gov/pubmed/33890476 http://dx.doi.org/10.1161/JAHA.120.018932 |
work_keys_str_mv | AT derasmolaura clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents AT minicocciilenia clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents AT dicostanzoalessia clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents AT pignagiovanni clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents AT commodaridaniela clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents AT cecifabrizio clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents AT montalianna clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents AT brancatofrancesca clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents AT stancailaria clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents AT nicolucciantonio clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents AT ascioneandrea clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents AT galeanicola clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents AT carboneiacopo clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents AT franconemarco clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents AT maranghimarianna clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents AT arcamarcello clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents |